Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | APLS | BMY | AMGN | GILD | GSK |
Company | Apellis Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
Open | 42.73 | 43.56 | 309.53 | 65.18 | 44.30 |
High | 43.00 | 44.81 | 314.60 | 65.22 | 44.72 |
Low | 41.71 | 43.49 | 306.32 | 64.52 | 44.30 |
Last | 42.52 | 44.74 | 312.86 | 64.58 | 44.67 |
Change | +0.22 | +1.07 | +5.55 | -0.34 | +0.53 |
% Change | +0.52% | +2.45% | +1.81% | -0.52% | +1.20% |
Volume | 1,060,500 | 10,776,300 | 2,921,300 | 6,048,500 | 4,924,600 |
20-Day Average Volume | 1,905,185 | 14,356,360 | 2,907,275 | 7,462,300 | 3,389,955 |
Previous Close | 42.30 | 43.67 | 307.31 | 64.92 | 44.14 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 47.64 | 46.17 | 279.47 | 66.10 | 41.67 |
20-Day Raw Stochastic | 24.75% | 22.60% | 84.27% | 5.83% | 99.10% |
20-Day Relative Strength | 35.12% | 35.71% | 68.03% | 31.74% | 69.57% |
Weighted Alpha | -28.62 | -34.69 | +35.65 | -21.62 | +28.50 |
Today's Opinion | 72% Sell | 100% Sell | 56% Buy | 100% Sell | 88% Buy |
Previous Opinion | 72% Sell | 100% Sell | 56% Buy | 100% Sell | 88% Buy |
Last Month's Opinion | 24% Buy | 48% Sell | 40% Sell | 100% Sell | 56% Buy |
Performance | |||||
5-Days | |||||
%Chg | -10.47% since 05/02/24 | +2.38% since 05/02/24 | +12.38% since 05/02/24 | -1.15% since 05/02/24 | +3.04% since 05/02/24 |
Low | 41.57 on 05/08/24 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 43.17 on 05/06/24 |
High | 49.06 on 05/06/24 | 44.81 on 05/09/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 44.72 on 05/09/24 |
1-Month | |||||
%Chg | -22.86% since 04/09/24 | -13.29% since 04/09/24 | +15.72% since 04/09/24 | -7.66% since 04/09/24 | +9.27% since 04/09/24 |
Low | 38.22 on 04/30/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 39.15 on 04/18/24 |
High | 57.85 on 04/11/24 | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 44.72 on 05/09/24 |
3-Month | |||||
%Chg | -37.98% since 02/09/24 | -10.18% since 02/09/24 | +7.47% since 02/09/24 | -12.34% since 02/09/24 | +6.59% since 02/09/24 |
Low | 38.22 on 04/30/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 39.15 on 04/18/24 |
High | 71.90 on 02/26/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 44.72 on 05/09/24 |
6-Month | |||||
%Chg | -8.28% since 11/09/23 | -11.25% since 11/09/23 | +18.48% since 11/09/23 | -13.87% since 11/09/23 | +29.63% since 11/09/23 |
Low | 38.22 on 04/30/24 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 33.89 on 11/10/23 |
High | 73.80 on 01/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 44.72 on 05/09/24 |
Key Statistics | |||||
Market Capitalization, $K | 5,130,736 | 88,523,448 | 164,851,840 | 80,830,400 | 91,477,504 |
Shares Outstanding, K | 121,294 | 2,027,100 | 536,435 | 1,245,077 | 2,072,440 |
Annual Sales | 396,590,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 37,725,000,000 |
Annual Net Income | -528,630,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 6,129,940,000 |
Last Quarter Sales | 146,380,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 9,337,020,000 |
Last Quarter Net Income | -88,580,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 1,326,430,000 |
60-Month Beta | 0.97 | 0.45 | 0.60 | 0.22 | 0.65 |
Per-Share Information | |||||
Most Recent Earnings | -0.54 on 05/07/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 1.09 on 05/01/24 |
Latest Earnings Date | 05/07/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/01/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | 0.397 on 02/22/24 |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | 05/16/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 41.94 | 16.12 | 16.24 | 10.93 |